A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma

Status:
Completed

Trial end date:
2015-02-01

Target enrollment:

Participant gender:

This study is designed to investigate the efficacy and safety of QBX258 in subjects with moderate to severe asthma.

Phase 2

Novartis Pharmaceuticals